Affidea Group is pleased to announce the appointment of Frans van Houten, former CEO of Philips, as a non-executive Supervisory Board Member. Recognized as a visionary in healthcare innovation and technology sectors, Frans van Houten will use his leadership skills and insights to significantly enhance Affidea's aspirations for growth and digital innovation.
Guy Blomfield, CEO of Affidea Group and Chairman of the Management Board, stated: “We warmly welcome Frans to our Supervisory Board. His expertise in pioneering innovative, connected, and patient-focused solutions will be relevant to Affidea's strategic growth plans. His track record in digital transformations is particularly important. The company will benefit from his experience in standardizing and optimizing processes and data management, leading to optimal care pathways and, progressively, the adoption of AI solutions.”
Frans van Houten joins the Supervisory Board alongside Affidea management, GBL representatives, and Dimitris Moulavasilis, who joined as a non-executive Director in 2022. Dimitris Moulavasilis is the current CEO of Diaverum and former CEO of Affidea.
Source: Affidea
